For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260130:nRSd1739Ra&default-theme=true
RNS Number : 1739R Blackfinch Spring VCT PLC 30 January 2026
Blackfinch Spring VCT PLC (the "Company")
Notification of Admission of Further Securities to Trading (PRM 1.6.4R)
Further to the Company's Issue of Equity announcement on 28 January 2026 in
respect of the allotment of new Ordinary Shares under the Company's Offer for
Subscription and following the admission to trading of those new Ordinary
Shares, the following additional information is disclosed in accordance with
The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM
1.6.4R.
1 Details of the issuer
a) Name Blackfinch Spring VCT PLC
b) LEI 254900F3ZHVS78UV6D89
2 Details of the transferable securities admitted to trading
a) Name, type and identification code Ordinary Shares of 1p each;
ISIN: GB00BKV46W45
b) Regulated market London Stock Exchange - Main Market
c) Number of further securities admitted 2,134,986 ordinary shares
d) Total number of securities in issue following admission 74,098,057 ordinary shares
e) Fungibility Fully fungible with existing Ordinary Shares
3 Admission details
a) Date of admission 30 January 2026
b) Prospectus information Prospectus: 11 September 2025
Supplementary: N/A
Prospectus Link:
https://blackfinch.investments/assets/Final_Blackfinch_Spring_Venture_Capital_Trust_Prospectus_2025_V13_61fd01f3f7.pdf
(https://blackfinch.investments/assets/Final_Blackfinch_Spring_Venture_Capital_Trust_Prospectus_2025_V13_61fd01f3f7.pdf)
c) Coverage of notification All admissions up to and including 30 January 2026
4 Contact details
a) Name and contact number Company Secretary, City Partnership (UK) Limited, 01484 240 910
Manager, Blackfinch Investments Limited, 01452 717070
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCAKKBPABKDFDN
Copyright 2019 Regulatory News Service, all rights reserved